298 related articles for article (PubMed ID: 16759511)
1. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
[TBL] [Abstract][Full Text] [Related]
2. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial.
Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B
Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735
[TBL] [Abstract][Full Text] [Related]
3. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
5. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
6. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
Parmigiani S; Panza C; Bevilacqua G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
[TBL] [Abstract][Full Text] [Related]
7. [Effect of pulmonary surfactant on Th1/Th2 balance in neonates with respiratory distress syndrome].
Zhai SF; Liu CQ; Ping LL; Tian BL
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):893-7. PubMed ID: 23234772
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
Chen A; Shi LP; Zheng JY; Du LZ
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
[TBL] [Abstract][Full Text] [Related]
10. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
[TBL] [Abstract][Full Text] [Related]
12. Bovine Surfactant Replacement Therapy in Neonates of Less than 32 Weeks' Gestation: A Multicenter Controlled Trial of Prophylaxis versus Early Treatment in China--a Pilot Study.
Kong X; Cui Q; Hu Y; Huang W; Ju R; Li W; Wang R; Xia S; Yu J; Zhu T; Feng Z
Pediatr Neonatol; 2016 Feb; 57(1):19-26. PubMed ID: 26059103
[TBL] [Abstract][Full Text] [Related]
13. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
Bevilacqua G; Parmigiani S;
J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
[TBL] [Abstract][Full Text] [Related]
14. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997
[TBL] [Abstract][Full Text] [Related]
15. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
[TBL] [Abstract][Full Text] [Related]
16. Acute and sustained effects of lucinactant versus poractant-alpha on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome.
Gastiasoro-Cuesta E; Alvarez-Diaz FJ; Rey-Santano C; Arnaiz-Renedo A; Loureiro-Gonzalez B; Valls-i-Soler A
Pediatrics; 2006 Feb; 117(2):295-303. PubMed ID: 16452346
[TBL] [Abstract][Full Text] [Related]
17. [The use of Curosurf with premature infants--the prevention or treatment of the neonatal RDS].
Iarŭkova N; Chernev T; Nikolov A
Akush Ginekol (Sofiia); 1998; 37(3):12-4. PubMed ID: 10204257
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of preterm neonates with severe respiratory distress syndrome using exogenous natural surfactants of porcine origin].
Valls i Soler A; López de Heredia I; Hernaéz Ortega E; Román Echevarría L; Gastiasoro Cuesta E; Robertson B
An Esp Pediatr; 1992 May; 36(5):375-81. PubMed ID: 1616198
[TBL] [Abstract][Full Text] [Related]
19. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
[TBL] [Abstract][Full Text] [Related]
20. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
